404 related articles for article (PubMed ID: 30064989)
1. The role of metabolism and tunneling nanotube-mediated intercellular mitochondria exchange in cancer drug resistance.
Hekmatshoar Y; Nakhle J; Galloni M; Vignais ML
Biochem J; 2018 Jul; 475(14):2305-2328. PubMed ID: 30064989
[TBL] [Abstract][Full Text] [Related]
2. Macrophage conditioned medium induced cellular network formation in MCF-7 cells through enhanced tunneling nanotube formation and tunneling nanotube mediated release of viable cytoplasmic fragments.
Patheja P; Sahu K
Exp Cell Res; 2017 Jun; 355(2):182-193. PubMed ID: 28412243
[TBL] [Abstract][Full Text] [Related]
3.
Lou E
Front Oncol; 2020; 10():559548. PubMed ID: 33324545
[TBL] [Abstract][Full Text] [Related]
4. Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy.
Vignais ML; Caicedo A; Brondello JM; Jorgensen C
Stem Cells Int; 2017; 2017():6917941. PubMed ID: 28659978
[TBL] [Abstract][Full Text] [Related]
5. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance.
Pasquier J; Guerrouahen BS; Al Thawadi H; Ghiabi P; Maleki M; Abu-Kaoud N; Jacob A; Mirshahi M; Galas L; Rafii S; Le Foll F; Rafii A
J Transl Med; 2013 Apr; 11():94. PubMed ID: 23574623
[TBL] [Abstract][Full Text] [Related]
6. Identification and Characterization of Tunneling Nanotubes for Intercellular Trafficking.
Sáenz-de-Santa-María I; Henderson JM; Pepe A; Zurzolo C
Curr Protoc; 2023 Nov; 3(11):e939. PubMed ID: 37994667
[TBL] [Abstract][Full Text] [Related]
7. Tunneling Nanotubes: A Versatile Target for Cancer Therapy.
Sahu P; Jena SR; Samanta L
Curr Cancer Drug Targets; 2018; 18(6):514-521. PubMed ID: 29189162
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and Rho GTPases in the biogenesis of tunnelling nanotubes: implications in disease and therapy.
Raghavan A; Rao P; Neuzil J; Pountney DL; Nath S
Cell Mol Life Sci; 2021 Dec; 79(1):36. PubMed ID: 34921322
[TBL] [Abstract][Full Text] [Related]
9. Cell communication by tunneling nanotubes: Implications in disease and therapeutic applications.
Mittal R; Karhu E; Wang JS; Delgado S; Zukerman R; Mittal J; Jhaveri VM
J Cell Physiol; 2019 Feb; 234(2):1130-1146. PubMed ID: 30206931
[TBL] [Abstract][Full Text] [Related]
10. Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies.
Soundara Rajan T; Gugliandolo A; Bramanti P; Mazzon E
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423160
[TBL] [Abstract][Full Text] [Related]
11. Tunneling nanotubes and mesenchymal stem cells: New insights into the role of melatonin in neuronal recovery.
Luchetti F; Carloni S; Nasoni MG; Reiter RJ; Balduini W
J Pineal Res; 2022 Aug; 73(1):e12800. PubMed ID: 35419879
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Tunneling Nanotubes in Wharton's jelly Mesenchymal Stem Cells. An Intercellular Exchange of Components between Neighboring Cells.
Sanchez V; Villalba N; Fiore L; Luzzani C; Miriuka S; Boveris A; Gelpi RJ; Brusco A; Poderoso JJ
Stem Cell Rev Rep; 2017 Aug; 13(4):491-498. PubMed ID: 28214945
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Transfer in Cancer: A Comprehensive Review.
Zampieri LX; Silva-Almeida C; Rondeau JD; Sonveaux P
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806730
[TBL] [Abstract][Full Text] [Related]
14. Tunneling Nanotubes: The Fuel of Tumor Progression?
Pinto G; Brou C; Zurzolo C
Trends Cancer; 2020 Oct; 6(10):874-888. PubMed ID: 32471688
[TBL] [Abstract][Full Text] [Related]
15. Tunneling nanotubes: The intercellular conduits contributing to cancer pathogenesis and its therapy.
Melwani PK; Pandey BN
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189028. PubMed ID: 37993000
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial transfer in tunneling nanotubes-a new target for cancer therapy.
Guan F; Wu X; Zhou J; Lin Y; He Y; Fan C; Zeng Z; Xiong W
J Exp Clin Cancer Res; 2024 May; 43(1):147. PubMed ID: 38769583
[TBL] [Abstract][Full Text] [Related]
17. B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment.
Polak R; de Rooij B; Pieters R; den Boer ML
Blood; 2015 Nov; 126(21):2404-14. PubMed ID: 26297738
[TBL] [Abstract][Full Text] [Related]
18. Tunneling Nanotubes as a Novel Route of Cell-to-Cell Spread of Herpesviruses.
Panasiuk M; Rychłowski M; Derewońko N; Bieńkowska-Szewczyk K
J Virol; 2018 May; 92(10):. PubMed ID: 29491165
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
20. Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells.
Bukoreshtliev NV; Wang X; Hodneland E; Gurke S; Barroso JF; Gerdes HH
FEBS Lett; 2009 May; 583(9):1481-8. PubMed ID: 19345217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
